Generating your feed, please be patient ...

Latest news

Zootzle IntelligenceSafety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial - The Lancet | Zootzle